InvestorsHub Logo
Post# of 200622
Next 10
Followers 5
Posts 156
Boards Moderated 0
Alias Born 03/30/2019

Re: None

Wednesday, 08/07/2019 7:35:10 PM

Wednesday, August 07, 2019 7:35:10 PM

Post# of 200622
Company is due to release 10Q next week. Unless they get the merger closed prior to releasing the 10Q, I wouldn't be surprised to see the 10Q delayed. If management stays in line with their current strategy, it would make no sense for them to drop a solid 10Q (which I believe will be the case) before the debt is settled since it will have the same affect on volume and the pps that a solid press release would. Plus, releasing a 10Q could risk spoiling any positive momentum associated with future releases since a lot of information will end up being disclosed there.

As much as the impatient hate it, I really think the company is being smart by not releasing anything. Generally in these types of situations, you see OTC mgmt release fluff news just to keep momentum going. While that is great and all short-term, I view that with great skepticism because it means they have no real positive items coming down the pipeline. PCT's lack of news leads me to believe they really do have something substantial coming and are waiting to release it at the perfect moment. Clearly they have things that they could talk about (i.e. innovation award, new deals, strategy, merger, etc.). So by not talking about some of the positive developments at a time when all eyes are on them, it tells me that they are working on shedding the toxic debt which will in turn give their upcoming releases much more effect on the pps.

If less debt and more sales doesn't get you excited, I don't know what does. Exciting things ahead in my opinion.